Medtecs International Corporation Limited (SGX:546)
Singapore · Delayed Price · Currency is SGD 0.1160
-0.0020 (-1.69%)
At close: Sep 11, 2026
SGXC:546 Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 63 | 64 | 76 | 101 | 109 | 191 | |
Market Cap Growth | -7.20% | -15.11% | -25.27% | -7.00% | -43.01% | -65.19% |
Enterprise Value | 62 | 67 | 69 | 92 | 78 | 127 |
Last Close Price | 0.12 | 0.12 | 0.14 | 0.19 | 0.20 | 0.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 8.18 |
Forward PE | - | 1.96 | 1.96 | 1.96 | 1.96 | 3.22 |
PS Ratio | 0.58 | 0.63 | 1.02 | 1.46 | 1.45 | 0.98 |
PB Ratio | 0.48 | 0.49 | 0.52 | 0.59 | 0.53 | 0.76 |
P/TBV Ratio | 0.49 | 0.51 | 0.54 | 0.61 | 0.55 | 0.77 |
P/FCF Ratio | - | - | - | - | - | 10.33 |
P/OCF Ratio | 24.78 | - | 23.69 | - | 64.25 | 4.71 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.56 | 0.66 | 0.93 | 1.32 | 1.03 | 0.66 |
EV/EBITDA Ratio | - | - | - | - | - | 4.80 |
EV/EBIT Ratio | - | - | - | - | - | 5.91 |
EV/FCF Ratio | - | - | - | - | - | 6.89 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.21 | 0.21 | 0.13 | 0.09 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.78 |
Debt / FCF Ratio | - | - | - | - | - | 1.17 |
Net Debt / Equity Ratio | -0.01 | 0.04 | -0.04 | -0.01 | -0.10 | -0.22 |
Net Debt / EBITDA Ratio | 0.47 | -1.29 | 0.15 | 0.04 | 0.50 | -2.10 |
Net Debt / FCF Ratio | 0.41 | -0.44 | 3.79 | 0.06 | 0.92 | -3.02 |
Asset Turnover | 0.63 | 0.56 | 0.36 | 0.30 | 0.28 | 0.63 |
Inventory Turnover | 2.72 | 2.17 | 1.36 | 1.22 | 1.39 | 1.95 |
Quick Ratio | 1.82 | 1.00 | 1.35 | 1.49 | 2.68 | 5.09 |
Current Ratio | 3.03 | 1.83 | 3.47 | 2.91 | 4.40 | 7.92 |
Return on Equity (ROE) | -4.27% | -4.56% | -20.21% | -15.91% | -17.20% | 8.63% |
Return on Assets (ROA) | -3.00% | -2.95% | -11.68% | -8.96% | -10.40% | 4.34% |
Return on Invested Capital (ROIC) | -6.43% | -6.40% | -24.50% | -18.72% | -23.30% | 10.58% |
Return on Capital Employed (ROCE) | -6.10% | -6.30% | -26.00% | -18.70% | -21.10% | 8.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.17% | -9.53% | -40.40% | -27.43% | -35.18% | 12.22% |
FCF Yield | -7.04% | -18.09% | -1.77% | -15.73% | -20.00% | 9.68% |
Dividend Yield | - | - | - | - | - | 2.41% |
Payout Ratio | - | - | - | - | - | 131.70% |
Buyback Yield / Dilution | - | - | - | 0.07% | 0.30% | 0.46% |
Total Shareholder Return | - | - | - | 0.07% | 0.30% | 2.87% |